Volume 27, Number 8—August 2021
Research
Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
Figure 2

Figure 2. Growth and persistence of Bordetella pertussis in the nasal cavity of mice after low-dose–low-volume nasopharyngeal inoculation over time. C57BL/6 mice were inoculated intranasally with 500 CFU of B. pertussis in 5 µL phosphate-buffered saline for nasopharyngeal inoculations (blue squares) or 500,000 CFU in 50 µL for the pneumonic inoculations (red squares). The results were replicated in >4 study runs. B. pertussis colonization was assessed for the nasal cavities (A) and the lungs (B). Dotted lines indicate limit of detection. Error bars indicate SD of the mean. Inoc., inoculation.
1These authors contributed equally to this article.
2Current affiliation: University of British Columbia, Vancouver, British Columbia, Canada.
3Current affiliation: Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
4Current affiliation: Louisiana State University Health Science Center, Shreveport, Louisiana, USA.
5Current affiliation: Augusta University, Augusta, Georgia, USA.